Next science wound gel technology, a novel agent that inhibits biofilm development by gram-positive and gram-negative wound pathogens

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 6, 2014, Pages 3060-3072

  Miller, Kyle G ^a   Tran, Phat L ^a   Haley, Cecily L ^a   Kruzek, Cassandra ^a   Colmer Hamood, Jane A ^a   Myntti, Matt ^b   Hamood, Abdul N ^a  

^a Department of Immunology and Molecular Microbiology Department of Medical Education ^*  (United States)

^b Next Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; NEXT SCIENCE WOUND GEL TECHNOLOGY; TOPICAL AGENT; UNCLASSIFIED DRUG; GEL;

ACINETOBACTER BAUMANNII; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BIOFILM; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; SHELF LIFE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; WOUND; WOUND INFECTION; ACINETOBACTER INFECTIONS; ANIMAL; DRUG EFFECTS; GEL; GROWTH, DEVELOPMENT AND AGING; KLEBSIELLA INFECTIONS; MICROBIOLOGY; PHARMACOLOGY; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; TOPICAL DRUG ADMINISTRATION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS; BIOFILMS; FEMALE; GELS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; WOUND INFECTION;

EID: 84901283927     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00108-14     Document Type: Article

References (61)

1. Church D, Elsayed S, Reid O, Winston B, Lindsay R. 2006. Burn wound infections. Clin. Microbiol. Rev. 19:403-434. http://dx.doi.org/10.1128/CMR.19. 2.403-434.2006.
2. Rafla K, Tredget EE. 2011. Infection control in the burn unit. Burns 37:5-15. http://dx.doi.org/10.1016/j.burns.2009.06.198.
3. Gist S, Tio-Matos I, Falzgraf S, Cameron S, Beebe M. 2009. Wound care in the geriatric client. Clin. Interv. Aging 4:269-287. http://dx.doi.org/10.2147/ CIA.S4726.
4. Percival SL, Emanuel C, Cutting KF, Williams DW. 2012. Microbiology of the skin and the role of biofilms in infection. Int. Wound J. 9:14-32. http://dx.doi.org/10.1111/j.1742-481X.2011.00836.x.
5. Ricco JB, Thanh Phong L, Schneider F, Illuminati G, Belmonte R, Valagier A, Regnault De La Mothe G. 2013. The diabetic foot: a review. J. Cardiovasc. Surg. (Torino) 54:755-762.
6. Black CE, Costerton JW. 2010. Current concepts regarding the effect of wound microbial ecology and biofilms on wound healing. Surg. Clin. North Am. 90:1147-1160. http://dx.doi.org/10.1016/j.suc.2010.08.009.
7. Posluszny JA, Jr, Conrad P, Halerz M, Shankar R, Gamelli RL. 2011. Surgical burn wound infections and their clinical implications. J. Burn Care Res. 32:324-333. http://dx.doi.org/10.1097/BCR.0b013e31820aaffe.
8. Bowler PG, Duerden BI, Armstrong DG. 2001. Wound microbiology and associated approaches to wound management. Clin. Microbiol. Rev. 14:244-269. http://dx.doi.org/10.1128/CMR.14.2.244-269.2001.
9. Percival SL, Hill KE, Williams DW, Hooper SJ, Thomas DW, Costerton JW. 2012. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen. 20:647-657. http://dx.doi.org/10.1111/j.1524-475X.2012.00836.x.
10. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193. http://dx.doi.org/10.1128/CMR.15.2.167-193.2002.
11. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 35:322-332. http://dx.doi.org/10.1016/j.ijantimicag.2009.12.011.
12. Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK. 2005. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-mediated macrophage killing. J. Immunol. 175:7512-7518.
13. Stewart PS, Costerton JW. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138. http://dx.doi.org/10.1016/S0140-6736(01) 05321-1.
14. Edwards R, Harding KG. 2004. Bacteria and wound healing. Curr. Opin. Infect. Dis. 17:91-96. http://dx.doi.org/10.1097/00001432-200404000-00004.
15. Hart J. 2002. Inflammation. 2. Its role in the healing of chronic wounds. J. Wound Care 11:245-249.
16. Ovington L. 2003. Bacterial toxins and wound healing. Ostomy Wound Manage. 49(Suppl):8-12.
17. Schaber JA, Triffo WJ, Suh SJ, Oliver JW, Hastert MC, Griswold JA, Auer M, Hamood AN, Rumbaugh KP. 2007. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect. Immun. 75:3715-3721. http://dx.doi.org/10.1128/IAI.00586-07.
18. Kennedy P, Brammah S, Wills E. 2010. Burns, biofilm and a new appraisal of burn wound sepsis. Burns 36:49-56. http://dx.doi.org/10.1016/j.burns.2009.02. 017.
19. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, Costerton JW, Stewart PS. 2008. Biofilms in chronic wounds. Wound Repair Regen. 16:37-44. http://dx.doi.org/10.1111/j.1524-475X.2007.00321.x.
20. Malic S, Hill KE, Hayes A, Percival SL, Thomas DW, Williams DW. 2009. Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH). Microbiology 155:2603-2611. http://dx.doi.org/10.1099/mic.0.028712-0.
21. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322. http://dx.doi.org/10.1126/science.284.5418.1318.
22. Pruitt BA, Jr, McManus AT, Kim SH, Goodwin CW. 1998. Burn wound infections: current status. World J. Surg. 22:135-145. http://dx.doi.org/10. 1007/s002689900361.
23. Shirani KZ, Vaughan GM, Mason AD, Jr, Pruitt BA, Jr. 1996. Update on current therapeutic approaches in burns. Shock 5:4-16.
24. Ammons MC. 2010. Anti-biofilm strategies and the need for innovations in wound care. Recent Pat. Antiinfect. Drug Discov. 5:10-17. http://dx.doi.org/10. 2174/157489110790112581.
25. Davis SC, Martinez L, Kirsner R. 2006. The diabetic foot: the importance of biofilms and wound bed preparation. Curr. Diab. Rep. 6:439-445. http://dx.doi.org/10.1007/s11892-006-0076-x.
26. Wolcott RD, Kennedy JP, Dowd SE. 2009. Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J. Wound Care 18:54-56.
27. Bjarnsholt T, Kirketerp-Moller K, Kristiansen S, Phipps R, Nielsen AK, Jensen PO, Hoiby N, Givskov M. 2007. Silver against Pseudomonas aeruginosa biofilms. APMIS 115:921-928. http://dx.doi.org/10.1111/j.1600-0463.2007.apm-646. x.
28. Dowd SE, Sun Y, Smith E, Kennedy JP, Jones CE, Wolcott R. 2009. Effects of biofilm treatments on the multi-species Lubbock chronic wound biofilm model. J. Wound Care 18:508, 510-512.
29. Kostenko V, Lyczak J, Turner K, Martinuzzi RJ. 2010. Impact of silvercontaining wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob. Agents Chemother. 54:5120-5131. http://dx.doi.org/10.1128/AAC.00825-10.
30. Thomas S, McCubbin P. 2003. A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J. Wound Care 12:101-107.
31. Thorn RM, Austin AJ, Greenman J, Wilkins JP, Davis PJ. 2009. In vitro comparison of antimicrobial activity of iodine and silver dressings against biofilms. J. Wound Care 18:343-346.
32. Kadurugamuwa JL, Sin L, Albert E, Yu J, Francis K, DeBoer M, Rubin M, Bellinger-Kawahara C, Parr TR, Jr, Contag PR. 2003. Direct continuous method for monitoring biofilm infection in a mouse model. Infect. Immun. 71:882-890. http://dx.doi.org/10.1128/IAI.71.2.882-890.2003.
33. Winson MK, Swift S, Hill PJ, Sims CM, Griesmayr G, Bycroft BW, Williams P, Stewart GS. 1998. Engineering the luxCDABE genes from Photorhabdus luminescens to provide a bioluminescent reporter for constitutive and promoter probe plasmids and mini-Tn5 constructs. FEMS Microbiol. Lett. 163:193-202. http://dx.doi.org/10.1111/j.1574-6968.1998.tb13045.x.
34. Myntti MF. April 2010. Antimicrobial composition and methods of making and using same. US patent 20,100,086,576.
35. Myntti MF. April 2013. Antimicrobial compositions and methods employing same. US patent 20,130,089,593.
36. Hammond AA, Miller KG, Kruczek CJ, Dertien J, Colmer-Hamood JA, Griswold JA, Horswill AR, Hamood AN. 2011. An in vitro biofilm model to examine the effect of antibiotic ointments on biofilms produced by burn wound bacterial isolates. Burns 37:312-321. http://dx.doi.org/10.1016/j.burns.2010.09.017.
37. Nidadavolu P, Amor W, Tran PL, Dertien J, Colmer-Hamood JA, Hamood AN. 2012. Garlic ointment inhibits biofilm formation by bacterial pathogens from burn wounds. J. Med. Microbiol. 61:662-671. http://dx.doi.org/10.1099/jmm.0. 038638-0.
38. Rumbaugh KP, Diggle SP, Watters CM, Ross-Gillespie A, Griffin AS, West SA. 2009. Quorum sensing and the social evolution of bacterial virulence. Curr. Biol. 19:341-345. http://dx.doi.org/10.1016/j.cub.2009.01.050.
39. International Organization for Standardization. 2010. Biological evaluation of medical devices, part 10: tests for irritation and skin sensitization. ISO 10993-10:2010. ISO, Geneva, Switzerland.
40. International Organization for Standardization. 2012. Biological evaluation of medical devices, part 12: sample preparation and reference materials. ISO 10993-12:2012. ISO, Geneva, Switzerland.
41. International Organization for Standardization. 2006. Biological evaluation of medical devices, part 11: tests for systemic toxicity. ISO 10993-11: 2006. ISO, Geneva, Switzerland.
42. Organisation for Economic Co-operation and Development. 1987. OECD guidelines for the testing of chemicals: test 402, acute dermal toxicity. OECD iLibrary, Paris, France.
43. Francis KP, Joh D, Bellinger-Kawahara C, Hawkinson MJ, Purchio TF, Contag PR. 2000. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect. Immun. 68:3594-3600. http://dx.doi.org/10.1128/IAI.68.6.3594-3600.2000.
44. Bergin SM, Wraight P. 2006. Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst. Rev. 2006: CD005082.
45. Chambers H, Dumville JC, Cullum N. 2007. Silver treatments for leg ulcers: a systematic review. Wound Repair Regen. 15:165-173. http://dx.doi.org/10.1111/j.1524-475X.2007.00201.x.
46. Karlsmark T, Agerslev RH, Bendz SH, Larsen JR, Roed-Petersen J, Andersen KE. 2003. Clinical performance of a new silver dressing, Contreet Foam, for chronic exuding venous leg ulcers. J. Wound Care 12:351-354.
47. Leaper DJ. 2006. Silver dressings: their role in wound management. Int. Wound J. 3:282-294. http://dx.doi.org/10.1111/j.1742-481X.2006.00265.x.
48. Carter J, Zug KA. 2009. Phototherapy for cutaneous T-cell lymphoma: online survey and literature review. J. Am. Acad. Dermatol. 60:39-50. http://dx.doi.org/10.1016/j.jaad.2008.08.043.
49. Hooper SJ, Percival SL, Hill KE, Thomas DW, Hayes AJ, Williams DW. 2012. The visualisation and speed of kill of wound isolates on a silver alginate dressing. Int. Wound J. 9:633-642. http://dx.doi.org/10.1111/j.1742-481X.2012. 00927.x.
50. Ammons MC, Ward LS, James GA. 2011. Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings. Int. Wound J. 8:268-273. http://dx.doi.org/10.1111/j.1742-481X.2011. 00781.x.
51. Fong J, Wood F. 2006. Nanocrystalline silver dressings in wound management: a review. Int. J. Nanomed. 1:441-449. http://dx.doi.org/10.2147/ nano.2006.1.4.441.
52. Craigen B, Dashiff A, Kadouri DE. 2011. The use of commercially available-Amylase compounds to inhibit and remove Staphylococcus aureus biofilms. Open Microbiol. J. 5:21-31. http://dx.doi.org/10.2174/ 1874285801105010021.
53. Izano EA, Amarante MA, Kher WB, Kaplan JB. 2008. Differential roles of poly-N-Acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl. Environ. Microbiol. 74:470-476. http://dx.doi.org/10.1128/AEM.02073-07.
54. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. 2002. Extracellular DNA required for bacterial biofilm formation. Science 295:1487. http://dx.doi.org/10.1126/science.295.5559.1487. (Pubitemid 34173996)
55. Erdur B, Ersoy G, Yilmaz O, Ozkutuk A, Sis B, Karcioglu O, Parlak I, Ayrik C, Aksay E, Guryay M. 2008. A comparison of the prophylactic uses of topical mupirocin and nitrofurazone in murine crush contaminated wounds. Am. J. Emerg. Med. 26:137-143. http://dx.doi.org/10.1016/j.ajem.2007.03.030.
56. Fong J, Wood F, Fowler B. 2005. A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits. Burns 31:562-567. http://dx.doi.org/10.1016/j.burns.2004.12.009.
57. Holloway BW, Krishnapillai V, Morgan AF. 1979. Chromosomal genetics of Pseudomonas. Microbiol. Rev. 43:73-102.
58. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM. 1995. Common virulence factors for bacterial pathogenicity in plants and animals. Science 268:1899-1902. http://dx.doi.org/10.1126/science.7604262.
59. Liu PV. 1966. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. II. Effects of lecithinase and protease. J. Infect. Dis. 116:112-116. http://dx.doi.org/10.1093/infdis/116.1.112.
60. Malone CL, Boles BR, Lauderdale KJ, Thoendel M, Kavanaugh JS, Horswill AR. 2009. Fluorescent reporters for Staphylococcus aureus. J. Microbiol. Methods 77:251-260. http://dx.doi.org/10.1016/j.mimet.2009.02.011.
61. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. 1998. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280:295-298. http://dx.doi.org/10.1126/science.280. 5361.295.